Lung cancer outcomes significantly improved with...
A regimen of pre-surgical immunotherapy and chemotherapy followed by post-surgical immunotherapy significantly improved event-free...
MD Anderson and Generate:Biomedicines enter co-development...
The University of Texas MD Anderson Cancer Center and Generate:Biomedicines today announced a strategic collaboration to jointly...
MD Anderson’s Hagop Kantarjian, M.D., awarded highest honor...
The American Society of Clinical Oncology (ASCO) will present the 2023 David A. Karnofsky Memorial Award to Hagop Kantarjian, M.D...
MD Anderson Research Highlights for April 19, 2023
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
AACR: Single-cell study uncovers distinct immunosuppressive...
ABSTRACT: 5788
In a new study, researchers from The University of Texas MD Anderson Cancer Center created the largest single-cell...
AACR: Early trial results show benefits of FGFR inhibitors...
ABSTRACTS: CT016, CT018
Researchers from The University of Texas MD Anderson Cancer Center presented promising findings...
AACR: Mutations in three key genes associated with poor...
ABSTRACT: 3431
A new study led by researchers at The University of Texas MD Anderson Cancer Center discovered that co-occurring...
AACR: Novel allogeneic CAR T cell therapy delivers...
ABSTRACT: CT011
The CD70-targeting allogeneic chimeric antigen receptor (CAR) T cell therapy, ALLO-316, demonstrated encouraging...
AACR: YAP/TEAD inhibitor VT3989 is well tolerated and shows...
ABSTRACT: CT006
The first-in-class YAP/TEAD inhibitor VT3989 was well tolerated with durable antitumor responses in patients with...
MD Anderson Research Highlights AACR 2023 Special Edition
The University of Texas MD Anderson Cancer Center’s Research Highlights showcases the latest breakthroughs in cancer care, research...
Andy Futreal and Helen Piwnica-Worms elected Fellows of the...
Two researchers from The University of Texas MD Anderson Cancer Center have been elected to the 2023 class of Fellows of the American...
MD Anderson applauds NCI’s National Cancer Plan
The University of Texas MD Anderson Cancer Center applauds the National Cancer Institute’s (NCI) National Cancer Plan and its...